What Cerebriu does

Cerebriu is a Danish health technology company founded in 2018 that develops Apollo, a CE-marked AI software suite designed to automate brain MRI workflows from image acquisition through diagnosis. The platform comprises three integrated modules: Smart Priority (real-time scan monitoring that flags critical findings such as infarcts, hemorrhages, and tumors as they emerge during acquisition), Smart Protocol (real-time protocol adaptation that suggests or applies sequence modifications while the patient remains on the scanner table), and Smart Reading (AI-driven worklist prioritization and triage across multiple scanners and facilities). Cerebriu's AI was trained on multi-hospital datasets and validated in a 995-patient European Journal of Radiology study demonstrating 89% sensitivity and 90% specificity for acute ischemic lesion detection.

Apollo is regulated as a medical device in the EU under MDR 2017/745 Article 120 and achieved the first-ever CE-mark for embedded clinical AI integrated into MRI scanner consoles through a flagship OEM partnership with Siemens Healthineers via the SHS Open Workflow. The company runs its inference on Oracle Cloud Infrastructure GPU clusters, including NVIDIA GB200 NVL72 systems. Customers span hospitals, radiology centers, stroke centers, and teleradiology providers across Europe, Asia, the Middle East, and the US (clinical validation), including Copenhagen University Hospital, Oslo University Hospital, Clalit Health Services, Soroka Medical Center, Guy's and St Thomas' NHS Foundation Trust, UMC Utrecht, and Assuta Medical Centers.

Cerebriu monetizes through three revenue streams: OEM software licensing to MRI manufacturers (notably Siemens Healthineers), subscription-based access via AI platform partners (deepcOS, CARPL.ai), and direct enterprise sales through Regional Sales Managers covering EMEA and APAC territories. Distribution partnerships include HCKonnect for Switzerland and North Africa, and a co-development partnership with Vista.ai for automated MR acquisition. Total funding raised is approximately €26.8 million across a Eurostars grant (2021), a $19M Series A led by North Ventures (September 2024), and a €9.4M strategic financing round (August 2025). FDA clearance is in progress.

Name

Cerebriu

Legal name

Cerebriu A/S

Website

https://cerebriu.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Cerebriu is a Danish health tech company developing Apollo, a CE-marked AI software suite for brain MRI workflow automation. It serves hospitals, radiology centers, and stroke centers across EMEA and APAC through OEM partnerships (Siemens Healthineers), AI platform distribution, and direct enterprise sales.

Ownership category

akta.pro rank

Product category

Medical Imaging AI Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industry

Medical Imaging AI (HDAAAEAH)

Keywords

• AI medical imaging
• Brain MRI workflow
• Radiology AI software
• MRI protocol optimization
• Medical imaging analytics

Headquarters

HQ city

Københoved

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. OEM Software Licensing: Cerebriu licenses its Apollo Software Suite to OEM partners like Siemens Healthineers for integration into MRI scanner consoles. The software is embedded at point of manufacture, generating recurring licensing revenue from OEM deployment.
2. Platform Subscription: AI platform and distributor partnerships (deepc, CARPL.ai) provide subscription-based access to Apollo modules. Healthcare providers access Smart Reading and other features through integrated platforms, creating recurring SaaS-type revenue.
3. Direct Enterprise Sales: Direct B2B sales of Apollo platform to hospitals, diagnostic groups, and imaging networks. Sales cycles involve clinical and executive stakeholder engagement with Regional Sales Managers covering EMEA and APAC territories.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels6 records

Core offering

Cerebriu develops Apollo, a CE-marked AI-powered Software Suite for brain MRI workflows. Apollo operates at the point of imaging to optimize the end-to-end brain MRI pathway from acquisition to diagnosis through three integrated modules: Smart Priority (real-time scan monitoring and critical finding alerts), Smart Protocol (real-time protocol adaptation while patient remains on scanner), and Smart Reading (AI-driven worklist prioritization and triage). The suite is sold to hospitals, radiology centers, and OEMs, including a dedicated OEM-embedded variant integrated into Siemens Healthineers MRI consoles.

Product overview

Cerebriu offers Apollo, an AI-powered Software Suite for brain MRI workflows. Apollo is a modular platform comprising three core AI modules — Smart Priority (real-time scan monitoring and critical finding alerts), Smart Protocol (real-time protocol adaptation), and Smart Reading (AI-driven worklist prioritization and triage) — that collectively automate the end-to-end brain MRI pathway from image acquisition through diagnosis. Apollo is regulated as a medical device in the EU (CE-marked under MDR 2017/745). Smart Protocol also exists as a dedicated OEM-embedded variant certified for integration into Siemens Healthineers MRI consoles (first-ever CE-mark for embedded clinical AI in MRI from a major OEM). The platform targets hospitals, radiology centers, stroke centers, and teleradiology providers, and is available through direct deployment, OEM partnerships, and AI platform distributors (deepcOS, CARPL.ai).

Differentiator

Problem solved

Functional benefit

Brands

• Apollo: AI-based Software Suite for brain MRI workflow optimization providing real-time alerts on critical conditions, on-table detection of critical findings for prioritized reading, and real-time adaptation of MR scanning protocols.

Products and services

• Apollo Software Suite

Quantifiable outcome

• 89% sensitivity and 90% specificity for acute ischemic lesion detection on brain MRI
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature4 records

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

• Siemens HealthineersflagshipOEM/ Whitelabel/ Licensing Partner · 1 August 2025Strategic OEM partnership with leading global MRI manufacturer. Cerebriu's Apollo Smart Protocol received CE-mark as the first-ever embedded clinical AI solution in MRI systems, integrated via SHS Open Workflow directly into Siemens Healthineers MRI scanner consoles. This landmark partnership enables deployment at scale through established medical imaging vendor channels.
• deepccoreTechnology or Integration · 1 February 2025Partnership with premier AI platform for medical imaging integration. Apollo Smart Reading integrated into deepcOS platform, enabling radiologists worldwide to access specialized brain MRI AI through seamless platform integration. deepc provides comprehensive radiology AI ecosystem with vendor-neutral validation and end-to-end integration.
• CARPL.aicoreTechnology or Integration · 1 January 2025Integration with world's largest radiology AI marketplace. Smart Reading becomes accessible to CARPL.ai's global network of healthcare providers, combining CARPL.ai's orchestration platform with Cerebriu's workflow automation for intelligent brain MRI triage and prioritization.
• AXREMminorGTM or Marketing Partner · 1 January 2025Membership in UK trade association for diagnostic imaging and radiotherapy. Active participation in AI Special Focus Group to shape future of AI in radiology and support responsible AI adoption in healthcare.
• HCKonnect (HCK)coreChannel Partner/ Reseller/ Distributor · 1 May 2024Distribution partnership covering Switzerland and North Africa. HCK's extensive distribution network and market expertise increases availability of Cerebriu's AI-powered neuroimaging tools. HCK Hub platform routes anonymized patient data to AI platforms for accelerated processing.
• Copenhagen University HospitalcoreStrategic or Co-development Partner · 1 January 2024Eurostars research partnership to develop AI software for stroke tissue window analysis. Cerebriu technology used to automatically identify patients eligible for thrombolysis/thrombectomy based on imaging, shifting from time-based to tissue-based stroke treatment assessment.
• Oslo University HospitalcoreStrategic or Co-development Partner · 1 January 2024Research collaboration with Computational Radiology and AI unit to clinically validate Cerebriu's novel stroke solution for real-time and instantaneous estimates of stroke onset and clinical outcomes after thrombectomy.
• Clalit Health ServicesminorStrategic or Co-development Partner · 1 January 2024Partnership to automate radiology workflows with AI in Israeli healthcare system.
• Soroka Medical CenterminorStrategic or Co-development Partner · 1 January 2024Partnership with Israeli medical center to implement AI-powered automation for radiology workflows.
• Vista.aicoreStrategic or Co-development Partner · 1 November 2023Partnership to automate MRI exams combining Vista.ai's AI-guided software that automates MRI scanning with Cerebriu's Smart Protocol for right-first-time imaging. Joint solution showcased at RSNA 2024, moving toward autonomous MRI scanner vision.

Scale indicators6 records

Direct peers

• RapidAI: RapidAI is a leading AI platform for neurovascular and stroke imaging, offering real-time triage and workflow tools that compete directly with Cerebriu's Apollo in the brain MRI/stroke workflow category served to hospitals and stroke centers.
• Viz.ai: Viz.ai provides AI-powered care coordination and imaging triage for neurovascular conditions (notably stroke), competing head-to-head with Cerebriu's Smart Priority/Smart Reading modules in hospital stroke pathways.
• Aidoc: Aidoc is a broad radiology AI platform that prioritizes urgent findings and integrates into hospital workflows. It overlaps with Cerebriu's worklist-prioritization and triage capabilities, serving the same enterprise radiology buyer.
• icometrix: icometrix specializes in AI for brain MRI quantification (notably multiple sclerosis and dementia), making it the closest anatomical peer to Cerebriu's brain-MRI focus and a potential competitor for hospital neurology imaging budgets.
• Qure.ai: Qure.ai offers FDA-cleared radiology AI across head CT, chest X-ray and other modalities, directly overlapping with Cerebriu's brain imaging AI category and global hospital distribution ambitions.

Emerging players

• Annalise.ai: Annalise.ai provides comprehensive radiology AI for chest and head CT/MRI triage, competing for the same hospital radiology AI budget as Cerebriu but with a broader modality footprint.
• Lunit: Lunit develops medical imaging AI for cancer screening and triage (notably chest and mammography), representing an adjacent emerging competitor in the broader radiology AI workflow category Cerebriu addresses.

Broad incumbents

• Siemens Healthineers: Siemens Healthineers is both Cerebriu's flagship OEM partner and a broad incumbent that ships its own AI-Rad Companion radiology AI suite. The dual role makes it both a critical channel and a potential competitor in embedded MRI AI.
• GE HealthCare: GE HealthCare offers Edison AI platform and MRI systems, representing the broad incumbent that Cerebriu's sales team competes against in hospital imaging AI purchasing decisions.
• Philips (IntelliSpace AI): Philips offers IntelliSpace AI and MRI scanners with embedded AI capabilities, positioning it as a broad incumbent competitor that Cerebriu must displace or partner with for hospital imaging AI deals.

Market position

Strengths5 records

Weaknesses5 records

Key risks3 records

Key highlights6 records

Customer concentration

• Xx.com/cerebriu
• YouTubeyoutube.com/channel/UCBpXcyfWEk5Cko-p0E0vAIQ
• LinkedInlinkedin.com/company/cerebriu

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds17 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cerebriu